Literature DB >> 24895138

Central nervous system infection after Onyx embolisation of arterio-venous malformations in two paediatric patients.

H Pulhorn1, J C Hartley, M Shanmuganathan, C H Lee, W Harkness, D N P Thompson.   

Abstract

BACKGROUND: Increasingly, Onyx is used for endovascular embolization of aneurysms and arterio-venous malformations. Although reports in the literature on the use of Onyx are favourable, there have been so far no reports on the central nervous system (CNS) infection rate after embolisation with Onyx and no recommendations as to the management of these infections. CASE REPORTS: We present two cases of paediatric patients who acquired CNS infection with Pseudomonas aeruginosa after Onyx embolisation of AVMs and describe their subsequent management.
CONCLUSIONS: Presence of established infection after Onyx embolisation should be dealt with by removal of infected material, administration of appropriate antibiotic therapy and supportive treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24895138     DOI: 10.1007/s00381-014-2447-y

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  11 in total

Review 1.  Central nervous system device infections.

Authors:  Edward Stenehjem; Wendy S Armstrong
Journal:  Infect Dis Clin North Am       Date:  2012-03       Impact factor: 5.982

2.  Onyx embolization for the treatment of brain arteriovenous malformations.

Authors:  Feng Xu; Wei Ni; Yujun Liao; Yuxiang Gu; Bin Xu; Bing Leng; Donglei Song
Journal:  Acta Neurochir (Wien)       Date:  2010-10-28       Impact factor: 2.216

3.  Late angiographic and clinical follow-up results of 100 consecutive aneurysms treated with Onyx reconstruction: largest single-center experience.

Authors:  H Saruhan Cekirge; Isil Saatci; M Halil Ozturk; Barbaros Cil; Anil Arat; Michel Mawad; Fikret Ergungor; Deniz Belen; Uygur Er; Sami Turk; Murat Bavbek; Zeki Sekerci; Ethem Beskonakli; Osman E Ozcan; Tuncalp Ozgen
Journal:  Neuroradiology       Date:  2006-01-04       Impact factor: 2.804

4.  Safety and clinical efficacy of Onyx for embolization of extracranial head and neck vascular anomalies.

Authors:  R Thiex; I Wu; J B Mulliken; A K Greene; R Rahbar; D B Orbach
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-31       Impact factor: 3.825

5.  Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients.

Authors:  R Jahan; Y Murayama; Y P Gobin; G R Duckwiler; H V Vinters; F Viñuela
Journal:  Neurosurgery       Date:  2001-05       Impact factor: 4.654

6.  Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique: long-term results in 350 consecutive patients with completed endovascular treatment course.

Authors:  Isil Saatci; Serdar Geyik; Kivilcim Yavuz; H Saruhan Cekirge
Journal:  J Neurosurg       Date:  2011-04-08       Impact factor: 5.115

Review 7.  Onyx: a unique neuroembolic agent.

Authors:  Michael Ayad; Eric Eskioglu; Robert A Mericle
Journal:  Expert Rev Med Devices       Date:  2006-11       Impact factor: 3.166

8.  Cerebral Aneurysm Multicenter European Onyx (CAMEO) trial: results of a prospective observational study in 20 European centers.

Authors:  Andrew J Molyneux; Saruhan Cekirge; Isil Saatci; Gyula Gál
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

9.  Onyx embolization of infectious intracranial aneurysms.

Authors:  Ramesh Grandhi; Nathan T Zwagerman; Guillermo Linares; Edward A Monaco; Tudor Jovin; Michael Horowitz; Brian T Jankowitz
Journal:  J Neurointerv Surg       Date:  2013-05-04       Impact factor: 5.836

10.  Onyx embolization for the endovascular treatment of infectious and traumatic aneurysms involving the cranial and cerebral vasculature.

Authors:  Ashutosh P Jadhav; Johnny C Pryor; Raul G Nogueira
Journal:  J Neurointerv Surg       Date:  2012-11-06       Impact factor: 5.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.